Home › Arch Development › Ralph R. Weichselbaum

RW

Ralph R. Weichselbaum — 34 Patents

ADArch Development: 16 patents #4 of 350Top 2%

TCThe University Of Chicago: 15 patents #13 of 1,377Top 1%

DIDana-Farber Cancer Institute: 14 patents #41 of 1,343Top 4%

BCBeth Israel Deaconess Medical Center: 1 patents #325 of 672Top 50%

MEMercian: 1 patents #54 of 110Top 50%

TFThe Uab Research Foundation: 1 patents #374 of 813Top 50%

Chicago, IL: #205 of 13,327 inventorsTop 2%

Illinois: #1,647 of 84,256 inventorsTop 2%

Overall (All Time): #100,737 of 4,157,543Top 3%

34 Patents All Time

Ralph R. Weichselbaum has been granted 34 US patents while listed as an inventor at Arch Development. The first was granted in 1996 and the most recent in May 2024. Ralph R. Weichselbaum ranks #100,737 of 4,157,543 US inventors in our database (top 2.4%). Patent records list Ralph R. Weichselbaum in Chicago, IL, US.

Patents per Year

Issued Patents All Time

Showing 1–25 of 34 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11986670	System and method for multi-site radiotherapy	Steven J Chmura, Shan Lu	2024-05-21
10561708	Anti-tumor therapy	Nikolai Khodarev, Ravi Sood, Bernard Roizman	2020-02-18
10421971	Anti-tumor therapy	Liufu Deng, Yang-Xin Fu, Nikolai Khodarev	2019-09-24
9790504	Anti-tumor therapy	Nikolai Khodarev, Ravi Sood, Bernard Roizman	2017-10-17
9198914	Methods and compositions for modulating RAD51 and homologous recombination	Philip P. Connell, Douglas K. Bishop	2015-12-01
8772261	Treatment of tumors with genetically engineered herpes virus	Bernard Roizman, Richard J. Whitley	2014-07-08
8597949	Methods and compositions for modulating RAD51 and homologous recombination	Philip P. Connell, Douglas K. Bishop	2013-12-03
8318691	Treatment of tumors with genetically engineered herpes virus	Bernard Roizman, Richard J. Whitley	2012-11-27
8034791	Activation of Egr-1 promoter by DNA damaging chemotherapeutics	Donald W. Kufe, Mitchell Posner, Helena Mauceri, James O. Park	2011-10-11
7919310	Constitutive gene expression in conjunction with ionizing radiation	Dennis E. Hallahan, Donald W. Kufe, Vikas P. Sukhatme	2011-04-05
7892740	Prognosis and therapy predictive markers and methods of use	Bernard Roizman, Andy Minn, Nikolai Khodarev, Edwardine Labay	2011-02-22
7838512	DNA damaging agents in combination with tyrosine kinase inhibitors	Donald W. Kufe	2010-11-23
7556935	Induction of apoptosis by cellular stress	Donald W. Kufe, Rima Kaddurah-Daouk	2009-07-07
7537894	Methods and kits for monitoring Barrett's metaplasia	Nikolai Khodarev, Eric Kimchi, Mitchell Posner	2009-05-26
7265356	Image-guided medical intervention apparatus and method	Charles Pelizzari, Chin-Tu Chen, Samuel Hellman	2007-09-04
7247297	Use of DF3/MUC1 regulated expression in gene therapy	Donald W. Kufe	2007-07-24	$32,547,000
7118862	Induction of apoptosis by cellular stress	Donald W. Kufe, Rima Kaddurah-Daouk	2006-10-10
7070968	DNA damaging agents in combination with tyrosine kinase inhibitors	Donald W. Kufe	2006-07-04
7041653	Gene transcription and ionizing radiation: methods and compositions	Dennis E. Hallahan, Vikas P. Sukhatme, Donald W. Kufe	2006-05-09
6846670	Genetically engineered herpes virus for the treatment of cardiovascular disease	Lewis B. Schwartz, Bernard Roizman	2005-01-25
6605712	Gene transcription and ionizing radiation: methods and compositions	Dennis E. Hallahan, Vikas P. Sukhatme, Donald W. Kufe	2003-08-12
6589981	Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives	Corinne Reimer, Naoki Agata, Tomio Takeuchi, Hiroyuki Kumagai, Takeo Yoshioka +2 more	2003-07-08	$11,956,000
6524832	DNA damaging agents in combination with tyrosine kinase inhibitors	Donald W. Kufe	2003-02-25
6486170	Phospholipase A2 inhibitors as mediators of gene expression	Dennis E. Hallahan, Donald W. Kufe	2002-11-26
6426351	Chelerythrine-based therapies for cancer	Donald W. Kufe, Steven J Chmura, Mary E. Dolan	2002-07-30